Skip to main content
. 2023 Aug 1;10:1148389. doi: 10.3389/fmolb.2023.1148389

TABLE 1.

p53-regulated genes that impact immune function.

p53-regulated gene Up/down regulation by p53 Function Ref.
CCL2 Pro-cancer: can promote polarization of M2 macrophages Hacke et al. (2010), Fei et al. (2021)
DR5 Anti-cancer: also known as TRAIL-R2, receptor for TRAIL that promotes cellular apoptosis upon TRAIL binding Wu et al. (1997)
Fas Anti-cancer: FasL receptor that promotes extrinsic cellular apoptosis pathways upon ligand binding Müller et al. (1998)
IRF5 Anti-cancer: activates the transcription of pro-inflammatory cytokines and mediates apoptosis in cancer cells Mori et al. (2002), Barnes et al. (2003), Hu et al. (2005), Honda and Taniguchi (2006), Yanai et al. (2007), Couzinet et al. (2008), Hu and Barnes (2009)
IRF9 Anti-cancer: contributes to p53-mediated upregulation of IFNs Muñoz-Fontela et al. (2008)
Pro-cancer: may promote cancer cell survival via IL6 & STAT3 activation
PD-L1 ↑/↓ Pro-cancer: binding to receptor PD-1 suppresses CD8+ T-cell activation Cortez et al. (2016), Thiem et al. (2019), Costa et al. (2020)
PKR Anti-cancer: supports p53-mediated tumor suppression, mediates inflammasome activation and release of HMGB1 Yoon et al. (2009), Lu et al. (2012)
TLRs Anti-cancer: stimulates pro-inflammatory cytokines in cancer cells & lymphocytes Muresan et al. (2020), Muresan et al. (2020)
TRAIL Anti-cancer: DR4/5 ligand expressed primarily by immune cells Kuribayashi et al. (2008)
ULBP1/2 Anti-cancer: enhances NK cell target recognition Textor et al. (2011)